FluoroMyelin™ Green Fluorescent Myelin Stain - Solution in Water
Citations & References (15)
Invitrogen™
FluoroMyelin™ Green Fluorescent Myelin Stain - Solution in Water
The FluoroMyelin™ Green fluorescent myelin stain enables quick and selective labeling of myelin in brain cryosections in a single 20-minuteRead more
Have Questions?
Catalog Number
Quantity
F34651
1 mL
Catalog number F34651
Price (MXN)
-
Quantity:
1 mL
The FluoroMyelin™ Green fluorescent myelin stain enables quick and selective labeling of myelin in brain cryosections in a single 20-minute labeling step plus washes. This stain can be used in conjunction with antibodies and other dyes, and with standard histochemical methods for cryosection material.
For Research Use Only. Not for use in diagnostic procedures.
Specifications
ColorGreen
Detection MethodFluorescence
For Use With (Equipment)Fluorescence Microscope
Label or DyeFluoroMyelin™ Green
Product TypeGreen Fluorescent Myelin Stain
Quantity1 mL
Shipping ConditionRoom Temperature
Sub Cellular LocalizationMyelin
Excitation/Emission479/598 nm
Product LineFluoroMyelin
Unit SizeEach
Contents & Storage
Store at room temperature and protect from light.
Frequently asked questions (FAQs)
I used one of your FluoroMyelin stains and noticed it stains cells other than glial cells. Is there something wrong with the product?
FluoroMyelin is a lipid stain, any lipid can be stained by it but there is a higher lipid content in myelin that it will stain much more intensely than other membranes.
Can the FluoroMyelin stains be used on neurons in culture?
We have only tested them on mouse brain cryosections. They might work on neurons in culture, but would likely stain the membrane and there would be some endocytosis of the stains. Myelin sheaths may show enhanced intensity.
Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning.
Authors:Lai WS, Xu B, Westphal KG, Paterlini M, Olivier B, Pavlidis P, Karayiorgou M, Gogos JA
Journal:Proc Natl Acad Sci U S A
PubMed ID:17077150
'There is accumulating evidence that AKT signaling plays a role in the pathogenesis of schizophrenia. We asked whether Akt1 deficiency in mice results in structural and functional abnormalities in prefrontal cortex (PFC). Exploratory transcriptional profiling revealed concerted alterations in the expression of PFC genes controlling synaptic function, neuronal development, myelination, ... More
Inhibitor of apoptosis protein (IAP) profiling in experimental autoimmune encephalomyelitis (EAE) implicates increased XIAP in T lymphocytes.
Authors:Moore CS, Hebb AL, Robertson GS,
Journal:J Neuroimmunol
PubMed ID:18055022
'In multiple sclerosis (MS) and its widely accepted animal model, experimental autoimmune encephalomyelitis (EAE), the failure of autoreactive immune cells to undergo apoptosis is thought to contribute to CNS tissue damage and disease progression. Promoting apoptosis of myelin-reactive immune cells in diseases such as MS, may delay disease progression and ... More
Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis.
'The misfolding of the prion protein (PrP(c)) is a central event in prion diseases, yet the normal function of PrP(c) remains unknown. PrP(c) has putative roles in many cellular processes including signaling, survival, adhesion, and differentiation. Given the abundance of PrP(c) in the developing and mature mammalian CNS, we investigated ... More
Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse.
Authors:Aoyama K, Suh SW, Hamby AM, Liu J, Chan WY, Chen Y, Swanson RA
Journal:Nat Neurosci
PubMed ID:16311588
Uptake of the neurotransmitter glutamate is effected primarily by transporters expressed on astrocytes, and downregulation of these transporters leads to seizures and neuronal death. Neurons also express a glutamate transporter, termed excitatory amino acid carrier-1 (EAAC1), but the physiological function of this transporter remains uncertain. Here we report that genetically ... More
Effect of chronic continuous or intermittent hypoxia and reoxygenation on cerebral capillary density and myelination.
Authors:Kanaan A, Farahani R, Douglas RM, Lamanna JC, Haddad GG
Journal:Am J Physiol Regul Integr Comp Physiol
PubMed ID:16322350
Chronic hypoxia, whether continuous (CCH) or intermittent (CIH), occurs in many neonatal pathological conditions, such as bronchopulmonary dysplasia and obstructive sleep apnea. In this study, we explored the effect of CCH and CIH on cerebral capillary density and myelination. We subjected CD-1 mice starting at postnatal day 2 to either ... More